This lecture will review the literature from the past 12 months which relates to infection and rheumatic disease. The principal areas covered will be (i) infection (e.g. porphyromonas gingivalis) as a risk factor for the development of arthritis; (ii) infection as a co-morbidity of rheumatic disease and (iii) infection as a complication of treatment (which may be surgical or medical). Most of the published literature on infection as a complication of treatment relates to fungal infections, hepatitis B and C, and tuberculosis occurring in patients receiving biologic therapy for rheumatoid arthritis. The literature on infection following surgery relates to infection of prosthetic joints.
Disclosure of Interest None Declared